There are four known stearoyl-CoA desaturase (SCD) enzyme isoforms in mouse and two in humans that are required for the biosynthesis of monounsaturated fatty acids, mainly oleate. SCD1 isoform plays a role in the regulation of energy metabolism and lipid synthesis, but the roles of the other SCD isoforms have not been investigated. Here we show that the SCD2 isoform is important in lipid synthesis in early development and is required for survival. SCD2-deficient (Scd2 ؊/؊ ) neonatal mice have a skin permeability barrier defect and a specific repartitioning of linoleic acid from epidermal acylceramide species into phospholipids. SCD2 expression is high in liver of wild-type mouse embryos and neonates between embryonic day 18.5 and 21 days of age and is decreased in adult mice. SCD1 expression, on the other hand, is induced after weaning. The liver, skin, and plasma triglyceride contents are decreased in the neonates but are not altered in the adult Scd2 ؊/؊ mice. These results indicate that, although SCD1 expression is important in adult mice, SCD2 is crucial in the synthesis of monounsaturated fatty acids that are required for maintaining normal epidermal permeability barrier function and biosynthesis of lipids during early skin and liver development. . MUFA are essential components of triglycerides (TG), phospholipids, cholesteryl esters (CEs), and wax esters (2). Four isoforms of SCD have been isolated from mouse (3-6) with two human homologues (7, 8). The four mouse SCD genes encode proteins of 350-360 aa with Ͼ80% amino acid sequence identity, and all are located within a 200-kb region on chromosome 19 (4). In adult mice, SCD1 isoform is expressed in lipogenic tissues, including liver, adipose tissue, and sebaceous glands. SCD2 isoform is ubiquitously expressed in most tissues except liver. SCD3 expression is restricted to the sebocytes in skin, Harderian gland, and preputial gland. SCD4 is mainly expressed in the heart (3, 4, 6, 9-11).
. MUFA are essential components of triglycerides (TG), phospholipids, cholesteryl esters (CEs), and wax esters (2) . Four isoforms of SCD have been isolated from mouse (3-6) with two human homologues (7, 8) . The four mouse SCD genes encode proteins of 350-360 aa with Ͼ80% amino acid sequence identity, and all are located within a 200-kb region on chromosome 19 (4) . In adult mice, SCD1 isoform is expressed in lipogenic tissues, including liver, adipose tissue, and sebaceous glands. SCD2 isoform is ubiquitously expressed in most tissues except liver. SCD3 expression is restricted to the sebocytes in skin, Harderian gland, and preputial gland. SCD4 is mainly expressed in the heart (3, 4, 6, (9) (10) (11) .
The presence of multiple SCD isoforms that share considerable sequence homology and catalyze the same biochemical reaction makes it difficult to rationalize the role of each SCD isoform in metabolism. We are using gene knockouts in mice to determine the physiological functions of the SCD isoforms in lipid metabolism. Mice lacking the SCD1 isoform are viable, with profound reductions in the levels of MUFA, particularly oleate, in most tissues that synthesize TG, CEs, wax esters, and alkyldiacyl glycerol (10, 12, 13) . Scd1-deficient mice are also resistant to diet-and leptin-deficiency-induced obesity, with increased energy expenditure and insulin sensitivity (14) (15) (16) . At 6 weeks old, they also develop alopecia, skin barrier abnormality, and close eye fissure with hypoplastic sebaceous and meibomian glands through a mechanism involving decreased production of wax esters, CE, and TG (13, 17, 18) . These findings suggest that SCD1 plays a crucial role in lipid synthesis and regulation of energy metabolism.
To determine the biological function of SCD2 isoform, we inactivated the SCD2 gene by homologous recombination. We report that SCD2 is important in lipid synthesis during early development and crucial for the formation of a functional skin permeability barrier. In contrast, SCD1 plays a role in lipid synthesis and energy metabolism in the later stages of life.
Materials and Methods
Generation of SCD2-Deficient Mice. Mouse genomic DNA for the targeting vector was cloned from the 129͞SV genomic library (13) . The targeting vector construct was generated by insertion of a fragment with 3Ј homology as a short arm and a fragment with 5Ј homology cloned adjacent to the neo expression cassette. The construct also contains a herpes simplex virus thymidine kinase cassette 3Ј to the homology arm, allowing positive͞ negative selection. The targeting vector was linearized and electroporated into embryonic stem cells. Selection with geneticin and gancyclovir was performed. The targeted cells were microinjected into C57BL͞6 blastocysts to generate the chimeric mice. The chimeric mice were then crossed five times with 129͞SvEv (Taconic Farms) females to generate Scd2 Ϫ/Ϫ mice having a genetic background of SV129. The Scd2 ϩ/Ϫ mice were also backcrossed with C57B6 mice for 10 generations to generate SCD2 Ϫ/Ϫ mice on a B6 background. For PCR genotyping, genomic DNA was amplified with primer A (5Ј-GGGCCTG-GCTTACGACCGGAAGAGAG-3Ј), which is located in exon 6; primer B (5Ј-ATAGCAGGCATGCTGGGGAT-3Ј), which is located in the neo gene (570-bp product, targeted allele); and primer C (5Ј-GTCACGAAGTTCCTCAGTTGCCAC-3Ј), which is located downstream of the targeting gene (750-bp product, wild-type allele). Mice were housed in a pathogen-free barrier facility (12 h light͞12 h dark cycle) and fed a standard chow diet (5008 test diet, PMI Nutrition, Richmond, IN). Newborn and 12-week-old (adult) mice were used. The committee on Animal Research of the University of Wisconsin, Madison, approved all procedures. All data shown in Figs. 1-5 were obtained by using mice in the 129Sv background.
RNA Analysis. Total RNA was isolated by using TRIzol reagent (Invitrogen). Fifteen micrograms of total RNA was separated by 1.0% agarose͞2.2 M formaldehyde gel electrophoresis and transferred onto a nylon membrane (Millipore). The membrane was hybridized with 32 P-labeled SCD cDNAs (SCD1, -2, -3, and -4) (3-6), ␤-cerebrosidase (Gba), transglutaminase-1, Involucrin, and Acyl-CoA:diacyl glycerol acyl transferase-2 (22) (kindly provided by R. V. Farese, Jr., Gladstone Institute, San Francisco). SCD3 expression was measured by real-time PCR, as described (11) . pAL15 expression was used as a control.
SCD Activity. Conversion of [1- 14 C] stearoyl-CoA to [1-14 C]oleate was used to measure SCD enzyme activity from individual liver and brain extracts, as described (10) .
Lipid Analysis. Epidermal lipids were extracted for 24 h at 37°C in chloroform͞methanol͞water 1:2:0.5 (vol͞vol) and then reextracted in chloroform͞methanol 1:1(vol͞vol) and chloroform͞ methanol 2:1 (vol͞vol) in the presence of 100 g͞ml butylated hydroxytoluene (19) . Liver lipids were extracted as described (10) . The extracted total lipids were subjected to TLC (Merck Darmstadt or Whatman). For epidermal glucosylceramides and phospholipids, the TLC was developed with chloroform͞ methanol͞water (70:30:5, vol͞vol). Ceramides were resolved twice by using chloroform͞methanol͞acetic acid (190:9:1, vol͞ vol). Neutral lipids were separated with hexane͞ether͞acetic acid (90:30:1, vol͞vol). After development, plates were dried, soaked in 8% (wt͞vol) phosphoric acid containing 10% cupric sulfate, and charred at 180°C for 15 min (19) . For quantitative analysis, lipids were extracted from TLC plates, and fatty acids were transmethylated and analyzed by GLC, as described (10).
Skin-Permeability Barrier Assay. Mice pups were treated with methanol at increasing concentrations of 25%, 50%, 75%, and 100% for 1 min each to modify the skin, to permit barrierdependent penetration by histological dyes. The mice were then rinsed in PBS, followed by incubation in 0.1% toluidine blue dye, as described (19, 20) .
Histological Analysis. Skin samples were taken for autopsy immediately after birth and processed for light and electron microscopy. For light microscopy, the skin was fixed in 10% neutral formaldehyde solution and embedded in paraffin. Sections were cut at 2 m and stained with hematoxylin͞eosin. For electron microscopy, samples were minced to Ͻ0.5 mm and fixed in Hepes buffer (0.16 M, pH 7.3) containing glutaraldehyde͞ formalin (1.25:0.5%) and 0.1 mM CaCl 2 . Ultrathin sections were examined in an electron microscope (Zeiss 10A) (23) .
Analysis of Acylceramide Synthesis in Epidermis.
Epidermal sheets (20 mg) prepared from newborn mice as described above were incubated in MEM containing 10% FCS and 5 Ci (1 Ci ϭ 37 GBq) 14 C-linoleic acid in 5% CO 2 ͞95% air for 16 h. After incubation, lipids were extracted by Bligh and Dyer's method (34) , and acylceramides were separated by TLC, as described above. The acylceramide fraction was scraped off the plate, and radioactivity was measured by using a liquid scintillation counter (24) .
Blood Chemistries. Plasma TG and free fatty acid (FFA) concentrations were measured by gas-liquid chromatography Plasma glucose levels were determined with a glucometer (Roche Diagnostics).
Hepatic TG Synthesis. Ten microcuries of [1, 2, 3 Ϫ3 H]glycerol dissolved in 0.9% NaCl was injected i.p. into newborn mice 15 min before they were killed. Hepatic lipids were extracted by using Bligh and Dyer's method and separated by TLC using hexane, ether, and acetic acid (90:30:1, vol͞vol) as developing solvent. Each lipid extract was scraped off the plate, and radioactivity was measured by using a liquid scintillation counter (25) .
Statistical Analysis. All data are expressed as means Ϯ SD. An unpaired Student t test was used to determine significance.
Results
To study the role of SCD2 isoform in lipid synthesis and development, we generated Scd2 Ϫ/Ϫ mice. Six exons of the gene were replaced with a neoresistant cassette by homologous recombination, resulting in the replacement of the complete coding region of the SCD2 gene (Fig. 1A) . This vector was used to generate embryonic stem cells and subsequently mice carrying the targeted SCD2 allele. PCR analysis of tail genomic DNA using appropriate primers indicates that the SCD2 gene was deleted in mice (Fig. 1B) . Because SCD isoforms are highly homologous and are located within a 200-kb region on chromosome 19, we determined whether the other SCD isoforms remained intact. As shown (Fig. 1C) , very high SCD2 expression was observed in brain of wild-type but not of Scd2 Ϫ/Ϫ mice. The brain of newborn and adult Scd2 Ϫ/Ϫ mice showed Ͼ80% reduction in SCD activity [2.4 Ϯ 0.5 vs. 15.7 Ϯ 0.6 pmol͞min͞mg in newborn mice (n ϭ 4, P Ͻ 0.001), 4.1 Ϯ 0.6 vs. 44.9 Ϯ 1.3 pmol͞min͞mg in adult (n ϭ 6, P Ͻ 0.01)]. SCD1 expression in the liver, SCD3 expression in the Harderian gland, and SCD4 expression in the heart were not altered in Scd2 Ϫ/Ϫ mice. Genotyping of newborn from heterozygote intercrosses showed Mendelian distribution (ϩ͞ϩ: ϩ͞Ϫ:Ϫ͞Ϫ ϭ 17:39:19), demonstrating that SCD2 deficiency does not cause embryonic lethality. At birth, Scd2 ϩ/Ϫ mice were indistinguishable from Scd2 ϩ/ϩ mice, whereas Ϸ70% of Scd2 Ϫ/Ϫ mice on 129SvEv died within 24 h after birth (Table 1) . Interestingly, 100% lethality was found in Scd2 Ϫ/Ϫ mice on a pure C57Bl6 background. Newborn Scd2 Ϫ/Ϫ mice were significantly smaller relative to the wild type (Fig. 1D, 1 .16 Ϯ 0.12 g vs. 1.38 Ϯ 0.14 g; n ϭ 6 P Ͻ 0.001). Adult Scd2 Ϫ/Ϫ mice that survived were fertile. Adult Scd2 Ϫ/Ϫ mice had a twisted tail (Fig. 1E) , suggesting that SCD2 expression plays a role in normal mouse-tail development.
A few hours after birth, the skin of the Scd2 Ϫ/Ϫ mice appeared dry and cracked. This observation suggested that Scd2 Ϫ/Ϫ deficiency causes dehydration in mice and indeed, a skinpermeability assay using o-toluidine blue dye revealed an impairment of skin permeability barrier function in Scd2 Ϫ/Ϫ mice ( Fig. 2A) . Body weights of newborn Scd2 Ϫ/Ϫ mice were rapidly reduced (Fig. 2B) , and histological examination of their skin showed an epidermal stratum corneum that was tightly packed and thickened (Fig. 2C) . The structure of the hair follicles was normal and, unlike the Scd1 Ϫ/Ϫ mice that exhibit alopecia and hypotrophic sebaceous glands, the Scd2 Ϫ/Ϫ that survived to adulthood had normal sebaceous glands and hair growth. To further assess the structural basis for epidermal permeability barrier abnormality in Scd2 Ϫ/Ϫ mice, we next examined the lamellar membrane system by electron microscopy (Fig. 2D) . There are normal numbers of lamellar bodies in the Scd2 Ϫ/Ϫ , but a decrease in their internal contents was observed. Scd2 Ϫ/Ϫ skin displayed delayed lamellar membrane maturation and phase separation forming a two-phase extracellular system. The wildtype control showed normal mature lamellar membranes in stratum corneum. The heterozygous mice did not show the skin barrier abnormalities, even though they expressed Ϸ50% of the SCD2 gene (data not shown).
Because we found a decrease in the internal contents of epidermal lamellar bodies, which normally contain glucosylceramides, phospholipids, and cholesterol, we next compared the epidermal lipid composition in Scd2 Ϫ/Ϫ mice vs. wild type by GLC. These analyses showed that epidermis from Scd2 Ϫ/Ϫ had 37%, 76%, 44%, and 21%, respectively, decrease in the contents of CE, TG, acylceramide, and glucosylacylceramide. In contrast, the FFA content was increased 1.4-fold (Fig. 3A) . The contents of the major phospholipids (phosphatidylcholine, phosphatidylethanolamine, and phophatidylinositol͞phospha-tidylserine) and free cholesterol were not different between Scd2
Ϫ/Ϫ and wild-type mice. The content of oleate and palmitoleate was reduced in the total lipids (TG, cholesterol esters, acylceramides, and phospholipids) and in the FFA pool of the epidermis of Scd2 Ϫ/Ϫ mice relative to the wild-type controls ( Fig. 3A and Table 2 ). The content of the corresponding saturated fatty acids mainly in the FFA pool was increased. The total content of linoleic acid [18:2(n-6)], which is a major fatty acid of skin epidermis, was not different between the Scd2 Ϫ/Ϫ mice and wild-type controls (Fig. 3B) . However, the content of 18:2(n-6) was decreased by Ͼ80% in the acylceramide fraction and increased by Ͼ30% in the phospholipid fraction of the Scd2 Ϫ/Ϫ mice relative to the controls (Table 2 ). These observations suggested that lack of SCD2 causes linoleic acid deficiency in the epidermal acylceramide of the Scd2 Ϫ/Ϫ mice. We then determined whether SCD2 deficiency alters the channeling and incorporation of linoleic acid into lipid fractions. As shown in Fig. 3C , the acylceramide synthetic rate from trace amounts of linoleic acid was reduced by 67% in the epidermis of the Scd2 Ϫ/Ϫ mice, whereas the phospholipid synthesis rate was increased by 23% (Fig. 3D) . These data demonstrated that linoleic acid was preferentially incorporated into phospholipid rather than the acylceraimde fraction of the epidermis of Scd2 Ϫ/Ϫ mice when endogenous MUFA were deficient.
To determine whether SCD2 deficiency might affect keratinocyte differentiation and͞or other genes related to skin barrier formation, we analyzed gene expression for transglutaminase-1, involucrin, Gba, acyl-CoA:diacylglycerol acyltransferase-2, SCD1, Male and female Scd2 ϩ/Ϫ mice at 8 -15 weeks old were bred. Genotypes were carried out by PCR by using appropriate primers. Age shown is when mice were genotyped. and SCD3 in the skin of 1-day-old wild-type and Scd2 Ϫ/Ϫ mice. Northern blot analysis showed that SCD2 expression in epidermis and dermis of newborn Scd2ϩ͞ϩ mice was comparable (Fig.  4A) . SCD1 was predominantly expressed in dermis, but its expression was induced by 2.8-and 3.3-fold, respectively, in epidermis and dermis of newborn Scd2 Ϫ/Ϫ mice, most likely to compensate for the loss of SCD2. SCD3 mRNA expression was induced in epidermis but not dermis of Scd2 Ϫ/Ϫ mice (Fig. 4B ). The expression of keratinocyte differentiation makers, transglutaminase-1, and involucrin were reduced by 73% and 41%, respectively, in the epidermis of the Scd2 Ϫ/Ϫ mice, whereas Gba and diacylglycerol acyltransferase-2 mRNA levels that have been shown to affect skin permeability barrier development (19, 20) were similar between wild-type and Scd2 Ϫ/Ϫ mice. We previously demonstrated that SCD1 is a crucial enzyme for hepatic TG synthesis and energy metabolism in adult mice. To determine whether SCD2 deficiency affects hepatic lipid metabolism, we analyzed lipid levels and substrates for energy metabolism in newborn Scd2 Ϫ/Ϫ mice. Hepatic TG contents and plasma levels were 48% (Fig. 5A ) and 44% (Fig. 5B) Ϫ/Ϫ and wild-type mice (data not shown). SCD activity was reduced by 70% in liver of newborn Scd2 Ϫ/Ϫ mice (Fig. 5C ), whereas the activity of adult Scd2 Ϫ/Ϫ mice was similar to that of adult Scd2 ϩ/ϩ mice (data not shown). As expected from the change in SCD activity, the contents of MUFA (palmitoleate, oleate, and vaccenate) in TG fractions of the livers of newborn Scd2 Ϫ/Ϫ mice were decreased by 55%, 73%, and 47%, respectively (Fig. 5D ), but in adult Scd2 Ϫ/Ϫ mice, the contents were similar to those of wild-type mice (data not shown). The content of palmitate in TG fraction was 40% lower in the liver of newborn Scd2 Ϫ/Ϫ mice (0.42 Ϯ 0.05 vs. 0.25 Ϯ 0.03 mg͞g liver, Data represent the content of major fatty acid in epidermis as g͞g epidermis. Standard errors (Ͼ25% of the mean) and minor fatty acids were omitted for clarity. Underlined values are significantly different from WT mice (n ϭ 5-6, P Ͻ 0.05). Cer(EOS), acylceramides; PL, phospholipids. (A) Full thickness skin of the newborn Scd2 Ϫ/Ϫ and Scd2 ϩ/ϩ mice was removed, the s.c. fat was scraped away under a dissecting microscope, and the sample was immersed in 10 mM EDTA in PBS for 1 h at 37°C. The skin was then chilled on ice, and the epidermis was quickly peeled away from the dermis. RNA was isolated from the epidermis and dermis and analyzed by Northern blot for expression of SCD1, SCD2, acyl-CoA:diacylglycerol acyl transferase-2, Gba, and involucrin. pAL15 expression was used as loading control. (B) SCD3 mRNA levels were measured by real-time PCR. * , P Ͻ 0.05 vs. Scd2 ϩ/ϩ mice (n ϭ 4ϳ6). n ϭ 5, P Ͻ 0.05), but there were no significant differences in the contents of other fatty acids (data not shown).
To determine whether SCD2 deficiency affects lipid synthesis in liver, we examined the in vivo synthesis rate of lipids by measuring the incorporation of i.p.-injected 3 H-glycerol into TG and phospholipids. The liver of newborn Scd2 Ϫ/Ϫ mice showed 54% reduction in TG synthesis rate relative to newborn Scd2 ϩ/ϩ mice (Fig. 5E ). In contrast, there was no difference in hepatic TG synthesis between adult Scd2 Ϫ/Ϫ and Scd2 ϩ/ϩ mice. The incorporation of 3 H-glycerol into the phospholipid fraction was not different between Scd2 Ϫ/Ϫ , wild-type newborn and adult mice (data not shown). This result suggests that SCD2 expression is important in TG synthesis in liver of neonates. To determine the developmental expression of the SCD genes, we analyzed the changes in hepatic expression of SCD1 and SCD2 in embryos, neonates, and adult wild-type mice. Fig. 5F shows that SCD2 mRNA expression is high in livers of mouse embryos and neonates between embryonic day 18.5 and 21 days of age and decreases in adult mice. On the other hand, SCD1 expression is very low in neonates and is induced after weaning (day 21). SCD3 and -4 expression was not detectable in liver.
Discussion
The mouse genome contains four well characterized ⌬-9 desaturase genes (SCD1-4) that are highly homologous at the nucleotide and amino acid levels and encode the same functional protein. The difference in biological function and the reasons for the existence of the multi-SCD isoforms in the mouse genome have not been addressed. Previous studies of mice with a disruption in the SCD1 gene isoform demonstrated that SCD1 and oleate, its major product, could act as a metabolic switch that increases fat synthesis and storage when SCD1 expression is high and conversely enhances fat oxidation when SCD1 expression is low. One of the consequences of this metabolic switch would be to protect mice against liver steatosis and diet-and leptin-induced obesity. In this study, we show that the SCD2 isoform plays a major role in lipid synthesis and metabolism in early skin and liver development and is important for survival, whereas SCD1 expression appears to be more important later in development.
Although Scd2 Ϫ/Ϫ mice were born in the expected Mendelian manner, most of the mice died within 24 h after birth, most likely as a result of severe dehydration due to skin permeability barrier dysfunction. The mechanism by which SCD2 deficiency leads to defective permeability barrier function is most probably due to alterations in epidermal lipid metabolism. Electron microscopic analysis of the epidermal stratum corneum of the Scd2 Ϫ/Ϫ mice revealed immature lamellar membranes and reductions in the internal contents of epidermal lamellar bodies, suggesting impaired delivery of lipid to lamellar granules, leading to insufficient deposition of lipids in the stratum corneum interstices. It has been known that the precursors of the striatum corneum lipids in lamellar granules are mainly cholesterol, phospholipids, and glucosylceramides (26, 27) . In agreement with EM analysis, lipid analysis showed that the content of glucosylceramide was significantly reduced in Scd2 Ϫ/Ϫ mice despite no alterations in the content of either phospholipids or cholesterol. Further conversion of epidermal glycosylceramides and acylglycosylceramides to ceramides and acylceramides, respectively, by Gba is required for skin permeability barrier homeostasis (19) . The amount of acylceramide, a unique and essential epidermal lipid (26, 27) , was reduced by 30% in the epidermis of Scd2 Ϫ/Ϫ mice, despite no alteration in Gba expression. Recently, Stone et al. (20, 22) reported that mice lacking diacylglycerol acyltransferase-2, a rate-limiting enzyme of TG synthesis, exhibited defective skin permeability barrier with lethality similar to Scd2 Ϫ/Ϫ mice. We also found a drastic reduction of TG and CE in the epidermis of Scd2 Ϫ/Ϫ neonatal mice, although the expression of epidermal diacylglycerol acyl transferase-2 was not altered. Thus, our results suggest that the reduction in lipid contents, including acylceramide, TG, and CE, in the epidermis of Scd2 Ϫ/Ϫ mice is due to lack of sufficient levels of endogenous MUFA.
Some aspects of the skin phenotype of Scd2 Ϫ/Ϫ mice resemble essential fatty acid deficiency that has been known to exist in mouse skin for decades. In this model, it has been postulated that linoleic acid [18:2(n-6)] is replaced by the accumulation of 20:3(n-9), which is an elongation and desaturation product of 18:1(n-9). Essential fatty acids are required for normal growth and skin function, and a deficiency in these fatty acids is characterized by growth retardation, skin abnormalities, and increased transepidermal water loss. In addition, linoleic acid is the major component of acylceramide, the major lipid involved in epidermal permeability barrier function (28) (29) (30) . Analysis of fatty acid composition of epidermal lipids showed that, although the total amounts of linoleic acid in the lipid fractions and FFA expression of SCD1 and -2 in mouse liver. The expression level of SCD1 and -2 in liver of mice at embryonic day 18.5, newborn, and 3, 7, 14, 21, and 56 days of age was measured by Northern blot analysis. Expression levels were obtained from pooled total RNA from four to five mice. pAL15 mRNA was used as a loading control.
pool were not different between Scd2 ϩ/ϩ and Scd2 Ϫ/Ϫ mice, the content of linoleic acid in acylceramide was reduced by Ͼ80%, whereas that in the phospholipid fraction was increased by Ͼ30%. In addition, very little linoleic acid was detected in TG and CE fractions of epidermis of either Scd2 Ϫ/Ϫ or wild-type mice. The mechanism consistent with our observations is that for Scd2 Ϫ/Ϫ mice to compensate for the reduction in the levels of MUFA required for the synthesis of phospholipids to maintain membrane fluidity and cell structure, linoleic acid coming into the embryo from maternal plasma is partitioned away from acylceramide synthesis into phospholipid synthesis. The reduced levels of acylceramide and deficiency of linoleic acid in the acylceramide fraction would be consistent with a skin permeability barrier defect in the Scd2 Ϫ/Ϫ mice. The mechanism of how the decision is made to partition linoleic acid is not known but is probably at the level of enzymes that activate linoleic acid before channeling into the phospholipid fraction and other metabolic pathways.
The expression of SCD1 was induced in the epidermis of Scd2 Ϫ/Ϫ neonates (Fig. 4) , and it is possible those mice that had the highest induction produced adequate amounts of MUFA that overcame the linoleic acid deficiency in the acylceramide fraction and had a functional skin permeability barrier. The degree of SCD1 induction in skin of Scd2 Ϫ/Ϫ mice was varied, and Scd2 Ϫ/Ϫ ͞Scd1 ϩ/Ϫ double mutant mice on 129 background showed 100% lethality (data not shown), suggesting that adequate levels of SCD1 expression in the skin were required for survival of the 30% of the Scd2 Ϫ/Ϫ mice that made it to adulthood. The epidermis of Scd2 Ϫ/Ϫ mice exhibited a reduction in the expression of involucrin and transglutaminase-1, makers of mature keratinocytes (31) (32) (33) , suggesting that SCD2 deficiency attenuates keratinocyte differentiation. Thus SCD2, as well as its products MUFA, may play a crucial role in keratinocyte differentiation and skin homeostasis in neonatal mice. Further experiments will be required to address this point.
We found that SCD2, but not SCD1, controls MUFA and TG synthesis in liver of neonatal mice. Because it has been well known that SCD2 expression is very low in adult liver (3, 4) , except in leptin-deficient adult ob͞ob mice (unpublished data), we therefore expected to observe no phenotype in liver of adult Scd2 Ϫ/Ϫ mice. Indeed, in livers of adult Scd2 Ϫ/Ϫ mice that survived, there was no change in SCD1 expression, SCD activity, fatty acid composition, and hepatic and plasma TG contents when compared with Scd2 ϩ/ϩ mice. However, newborn Scd2
showed decreases in hepatic SCD activity, MUFA, and hepatic and plasma TG contents. SCD2 is therefore a major isoform in liver of embryos and neonates and, consistent with its role in early development, its expression in liver was decreased before weaning and replaced by SCD1 at the weaning age (Fig. 5F) . We have also shown previously (12, 14) that in Scd1 Ϫ/Ϫ mice, the levels of hepatic TG and MUFA decrease as the mice age. Together, the results clearly show that SCD2 plays a crucial role in hepatic TG synthesis in early stages of life, whereas SCD1 expression is required in later stages. Although the mechanism of how SCD2 isoform is switched off and SCD1 is switched on during development has not been determined, many dietary nutrients, including vitamins, polyunsaturated fatty acids, and carbohydrates, which are known to influence SCD1 and SCD2 expression, might be involved in this isoform shift at weaning.
Two isoforms of SCD (SCD1 and -5) have been identified in the human genome (7, 8) . Based on its tissue distribution, it seems that human SCD5 plays a similar developmental role in lipid metabolism as mouse SCD2. In humans, a pericentric inversion of the SCD5 localized at chromosome 4 was found in two generations in a family with cleft lip, a common birth defect in humans (7) . Although no cleft-lip phenotype was observed in Scd2 Ϫ/Ϫ mice, we found an abnormal shape of tail in Scd2 Ϫ/Ϫ mice. Thus, MUFA due to SCD2 expression play a role in developmental processes in mouse. Based on our previous studies, SCD1 still remains a potential target in the treatment of liver steatosis, obesity, and diabetes in adult humans. The development of a selective inhibitor of SCD isoforms at the different stages of development would even be better.
